15 / PRNewswire-FirstCall / - GeneNews Limited ( TSX : GEN ) , a company focused on developing blood-based biomarker tests for the early detection of diseases and personalized health management , today announced that it has appointed Patrick Terry as its lead strategic advisor for the U.S. commercial launch of ColonSentry ( TM ) , the world 's fist blood-based test to determine a person 's current risk for colorectal cancer .